PCV51 IRBESARTAN IS COST-SAVING COMPARED TO AMLODIPINE AND STANDARD BLOOD PRESSURE TREATMENT IN PATIENTS WITH TYPE 2 DIABETES, HYPERTENSION AND NEPHROPATHY IN HUNGARY
Nov 1, 2003, 00:00
10.1016/S1098-3015(10)61695-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)61695-6/fulltext
Title :
PCV51 IRBESARTAN IS COST-SAVING COMPARED TO AMLODIPINE AND STANDARD BLOOD PRESSURE TREATMENT IN PATIENTS WITH TYPE 2 DIABETES, HYPERTENSION AND NEPHROPATHY IN HUNGARY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61695-6&doi=10.1016/S1098-3015(10)61695-6
First page :
Section Title :
Open access? :
No
Section Order :
141